A detailed history of Summit Global Investments transactions in Inogen Inc stock. As of the latest transaction made, Summit Global Investments holds 11,646 shares of INGN stock, worth $115,411. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,646
Holding current value
$115,411
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$8.31 - $11.09 $96,778 - $129,154
11,646 New
11,646 $107,000
Q4 2018

Feb 08, 2019

SELL
$112.83 - $239.74 $417,471 - $887,038
-3,700 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$123.8 - $192.48 $136,180 - $211,728
-1,100 Reduced 22.92%
3,700 $689,000
Q1 2018

May 03, 2018

BUY
$114.22 - $133.22 $548,256 - $639,456
4,800 New
4,800 $590,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $227M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.